To explore the molecular mechanisms of IPO5-mediated regulation in CRC cells, we applied CO-IP technology followed by mass spectrometry (MS) to identify the proteins interacting with IPO5 (Fig. 4a). Here, IPO5 is linked to colorectal carcinoma.